F8 and hemophilia A: In one additional case report, the family of a 15-month-old PUP with severe hemophilia A elected to start emicizumab primarily to avoid venipuncture and central venous access device; at 28 months of age, the child had not experienced a bleed and was yet to receive FVIII concentrates [65].